seviteronel Things To Know Before You Buy
Similar to TNBC, the purpose of AR during the management of estrogen receptor-positive (ER+) breast cancer is a location of Lively analysis. AR is expressed in as much as ninety% of ER+ tumors and preclinical data suggests that AR expression is related to resistance to both of those tamoxifen and aromatase inhibitors in ER+ cell lines [14–sixteen